Matsukiyococokara & Co. · TSE:3088
Matsukiyococokara & — 1H FY2025 Earnings Presentation
15 slides from Matsukiyococokara &'s earnings presentation, Nov 13, 2025
Slide 1: Supplementary Presentation for the Six Months Ended September 30, 2025
This document is a translation of the original Japanese document for reference purposes only. In the event of any discrepancy between this document and the Japanese original, the original shall prevail. Supplementary Presentation for the Six Months Ended September 30, 2025 Copyright 2025 November 13
Slide 2: Contents
目 次 Financial Results for 1H FY2025 Financial Summary (YoY) ・・・・・・ 2 Segment Results (YoY) ・・・・・・ 3 Segment Results (YoY) ) Excluding amortization of goodwill and trademark rights associated with the management ・・・・・・ 4 integration with cocokarafine Inc. Net Sales by Product ・・・・・・ 5 Balance Sheet ・
Slide 3: Financial Summary (YoY)
Financial Results for 1H FY2025 Financial Summary (YoY) ◼ Achieved record-high sales and profits for the first half of the fiscal year and operating profit exceeding the plan. ◼ Revenue increased due to the capture of inbound demand and strong performance of cosmetics, etc., and profit increased due
Slide 4: Segment Results (YoY)
Financial Results for 1H FY2025 Segment Results (YoY) ◼ In the Matsumotokiyoshi Group, both sales and profit increased due to factors such as the expansion of people's flow in urban and downtown areas and the increase in inbound tourism. ◼ Cocokarafine Group business, revenue increased due to the re
Slide 5: Segment Results (YoY) excluding goodwill and trademark amortization
Financial Results for 1H FY2025 Segment Results (YoY) Excluding amortization of goodwill and trademark rights totaling 3,618 million yen Reference associated with the management integration with cocokarafine Inc. Matsumoto-kiyoshi Group Business (Millions of yen) ■ Net sales ■ Operating 〇 Operating
Slide 6: Net Sales by Product
Financial Results for 1H FY2025 Net Sales by Product ◼ The composition ratio of the health and beauty category increased to 72.2%, driven by cosmetics, mainly in new merchandise. ◼ Gross profit margin improved due to steady promotion of priority measures and strengthening of sales of PB products, ex
Slide 7: Balance Sheet
Financial Results for 1H FY2025 Balance Sheet ◼ Total assets increased by approximately ¥5.1 billion from the end of the previous fiscal year. Liabilities increased by approximately ¥3.6 billion due to an increase in accounts payable - trade associated with the opening of new stores. ◼ Net assets in
Slide 8: Statement of Cash Flows
Financial Results for 1H FY2025 Statement of Cash Flows ◼ We have continued to actively and systematically implement shareholder returns, with share buybacks of approximately ¥15.3 billion, dividend payments of approximately ¥9.3 billion, and a decrease in financing cash flow of approximately ¥24.6
Slide 9: Store Openings, Closings, and Renovations in Japan
Financial Results for 1H FY2025 Store Openings, Closings, and Renovations in Japan ◼ Opened stores in major urban areas, including Matsumotokiyoshi Ikebukuro Higashiguchi Gosaro-mae store and Higashi-ginza store. ◼ Renewal and opening of GINZA FLAG as the fifth flagship store representing the Compan
Slide 10: FY2025 Financial Forecasts
Financial Forecasts for FY2025 FY2025 Financial Forecasts ◼ There are no revisions to the consolidated earnings forecast announced on May 9, 2025 (Millions of yen) Full Year FY2024 FY2025 Change Change % to net sales % to net sales (amount) (%) Net sales 1,061,626 1,100,000 38,373 3.6 Gross profit 3
Slide 11: Shareholder Return
Financial Forecasts for FY2025 Shareholder Return ◼ We have set a target dividend on equity (DOE) ratio of 6% and a dividend payout ratio of 50% for the fiscal year ending March 31, 2031. ◼ Maintain or increase dividends Progressive dividend policy. 円 35 ◼ We will flexibly implement share buyback, t
Slide 12: Quarterly Consolidated Financial Results
【Appendix】 Quarterly Consolidated Financial Results FY2024 FY2025 （Millions of yen/%） 1Q 2Q 1H 3Q 4Q Full Year 1Q 2Q 1H 3Q 4Q Full Year Net sales 259,749 265,979 525,729 275,791 260,105 1,061,626 273,643 275,451 549,094 Gross profit 89,241 93,115 182,357 96,201 93,676 372,235 94,283 97,276 191,559 G
Slide 13: Quarterly Segment Results
【Appendix】 Quarterly Segment Results FY2024 FY2025 （Millions of yen/％） 1Q 2Q 1H 3Q 4Q Full Year 1Q 2Q 1H 3Q 4Q Full Year Sales 162,010 166,075 328,085 173,795 165,346 667,226 175,393 176,430 351,823 Matsumoto- kiyoshi Segment Group 12,560 13,647 26,208 16,242 15,501 57,952 14,339 13,854 28,194 profi
Slide 14: Quarterly Net Sales and Gross Profit by Product
【Appendix】 Quarterly Net Sales and Gross Profit by Product FY2024 FY2025 (Millions of yen/％) 1Q 2Q 1H 3Q 4Q Full Year 1Q 2Q 1H 3Q 4Q Full Year Sales 88,378 90,809 179,187 96,478 93,085 368,752 91,887 93,125 185,012 Medical and Segment pharmaceutic al products profit 37,069 40,665 77,735 42,564 42,63
Slide 15: Cautionary Statement
Cautionary Statement This document contains future outlooks such as plans, forecasts, strategies, and others which are not historical fact and these are made by the management’s judgement based on the obtainable information at the time of the disclosure. Actual results may significantly differ from
MatsukiyoCocokara & — 1H FY2025 Earnings Presentation on 6ix